J1786 HCPCS Level II code: Injection, imiglucerase, 10 units
J1786 is the HCPCS code for “Injection, imiglucerase, 10 units” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1786Injection, imiglucerase, 10 units
Short description: Imuglucerase injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J1786 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2011
Where J1786 sits
- 1J codesDrugs administered other than orally
- 2Active code J1786Injection, imiglucerase, 10 units
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1786 mean?
J1786 is the HCPCS code for “Injection, imiglucerase, 10 units” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1786?
CMS lists J1786’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1786
All J codesJ1747Injection, spesolimab-sbzo, 1 mgJ1748Injection, infliximab-dyyb (zymfentra), 10 mgJ1749Injection, iloprost, 0.1 mcgJ1750Injection, iron dextran, 50 mgJ1756Injection, iron sucrose, 1 mgJ1757Injection, tividenofusp alfa-eknm, 1 mgJ1790Injection, droperidol, up to 5 mgJ1800Injection, propranolol hcl, up to 1 mgJ1805Injection, esmolol hydrochloride, 10 mgJ1806Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mgJ1807Injection, ethacrynate sodium, 1 mgJ1808Injection, folic acid, 0.1 mg